1-10 of 10
Emad Uddin Abro
Close
Sort by
Journal Articles

Identifying Early Suboptimal Hematological Response in Patients with AL Amyloidosis Treated with Bortezomib-Based Chemotherapy

Anthea Gibbons, Nirija Ranjit Anderson, Lipi Chakravorty, Fiona Kwok, Hasib Sidiqi, Simon Gibbs, Dariusz Korczyk, Emad Uddin Abro, Peter Mollee
Journal: Blood
Blood (2023) 142 (Supplement 1): 2030.
https://doi.org/10.1182/blood-2023-179219
Published: 2023
Journal Articles

Outcomes of Second Line Therapy for Light Chain Amyloidosis after Initial Therapy with a Bortezomib Based Regimen

Lipi Chakravorty, Anthea Gibbons, Nirija Anderson, Fiona Kwok, Dariusz Korczyk, Emad Uddin Abro, Stephanie Lam, Simon Gibbs, Peter Mollee, M Hasib Sidiqi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4781.
https://doi.org/10.1182/blood-2023-186335
Published: 2023
Journal Articles

A Phase 1/2 Multi-Center, Dose-Finding Study to Assess Safety, Tolerability, PK and Efficacy of ZN-d5, a Novel BCL-2 Inhibitor, for Treatment of Subjects with Relapsed/Refractory AL Amyloidosis

Efstathios Kastritis, Jeffrey V. Matous, Emad Uddin Abro, P. Taylor Eves, Cheng Zheng, Tony Fiorino, Jesus Berdeja
Journal: Blood
Blood (2022) 140 (Supplement 1): 4438–4439.
https://doi.org/10.1182/blood-2022-158617
Published: 2022
Journal Articles

A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Ing S Tiong, Devendra Hiwase, Emad Uddin Abro, Ashish Bajel, Emma Palfreyman, Sun Loo, Shaun Fleming, Chun Yew Fong, Tse-Chieh Teh, Adam Ivey, Andrew H Wei
Journal: Blood
Blood (2022) 140 (Supplement 1): 1453–1455.
https://doi.org/10.1182/blood-2022-163041
Published: 2022
Journal Articles

A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Ing S Tiong, Sun Loo, Emad Uddin Abro, Devendra Hiwase, Shaun Fleming, Ashish Bajel, Emma Palfreyman, Chun Yew Fong, Tse-Chieh Teh, Adam Ivey, Andrew H. Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 1261.
https://doi.org/10.1182/blood-2021-152583
Published: 2021
Journal Articles

Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

Joshua W.D. Tobin, MD, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, MD, David C. Hodgson, MD, Chengetai Dunduru, Stephen Bell, MBBS, James Gallo, Erica Tsang, MD, Xuan Tan, Jessica Pearce, MBBS, Jonathan Wong, MBBS, Robert Campbell, Shao Yang Tneh, MBBS, Sophie Shorten, Melissa Liet Hing Ng, Jacob Darch, Tara Cochrane, MBBS, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Emad Uddin Abro, MBBS, FRACP, FRCPA, BSc(Hons), Eliza Hawkes, Georgina Hodges, FRACP, MBBS, FRCPA, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Michael P Gilbertson, MBBS, FRACP, FRCPA, Anna Johnson, Roopesh R. Kansara, MD, Diego Villa, MD, Kerry J Savage, BSc, MD MSc, Kirk Lachlan Morris, FRACP, FRCPA, MBBS, Wojt Janowski, FRCPA, FRACP, Sumita Ratnasingam, MD FRACP, FRCPA, Robert Kridel, PhD MD, Chan Y. Cheah, Maher K Gandhi, PhD, Greg Hapgood, BMBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4148.
https://doi.org/10.1182/blood-2018-99-114097
Published: 2018
Journal Articles

Elevated LAG-3 Expression in the Tumor Microenvironement of Patients with DLBCL Is Associated with a Non-GCB Phenotype and Poor Prognosis

Colm Keane, MB BCh BAO PhD MBA, Soi C Law, PhD, Clare Gould, MBBS, Santiyagu Francis, PhD, Emad Uddin Abro, MBBS, FRACP, FRCPA, BSc(Hons), Joshua W.D. Tobin, MD, Simone Birch, MBBS, Grace Gifford, MD, Sara Gabreilli, William S. Stevenson, MBBS PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Anthony Gill, MD, Sanjiv Jain, MBBS, Donna Cross, Annette Hernadez, Sarah-Jane Halliday, Robert Bird, FRACP FRCP FRCPA MBBS MRCP, Mark Hertzberg, Maher K Gandhi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1576.
https://doi.org/10.1182/blood-2018-99-112830
Published: 2018
Journal Articles

A Critical Role for Intratumoral and Circulating LAG3 in Classical Hodgkin Lymphoma: Analysis from the Rathl Prospective Phase III International Clinical Trial

Emad Uddin Abro, BSc, FRACP, FRCPA, MBBS, Soi C Law, PhD, Colm Keane, MB BCh BAO PhDMBA, Simone Birch, MBBS, Muhammed Bilal Sabdia, BSc(Hons), Joshua W.D. Tobin, MD, Peter Johnson, MD, Judith Trotman, Leanne Berkahn, MD, Michael Fulham, Richard A Anderson, Anne L Saunderson, Jay Gunawardana, PhD, Donna Cross, Annette Hernandez, BS, Sarah-Jane Halliday, Robert Bird, FRACP,FRCP,FRCPA,MBBS,MRCP, W P Law, Devinder Gill, MD MRCP, FRCPath, Maher K Gandhi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1621.
https://doi.org/10.1182/blood-2018-99-112008
Published: 2018
Journal Articles

The Tumor Microenvironment Is Independently Prognostic of Conventional and Clinicogenetic Risk Models in Follicular Lymphoma

Joshua W.D. Tobin, MD, Colm Keane, MB, PhD, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Simone Birch, MBBS, Clare Gould, MBBS, Jay Gunawardana, PhD, Thanh Hoang, Ti Ma, BSci, Emad Uddin Abro, BSc, FRACP, FRCPA, MBBS, Mohamed Shanavas, MD, Hyung Yoo, Li Li, Paul Scuffham, Valentine Murigneux, Lynn Fink, PhD, Nicholas Matigian, Frank Vari, PhD, Santiyagu Francis, PhD, Maher K Gandhi, MB, FRACP, FRCPath, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 728.
https://doi.org/10.1182/blood.V130.Suppl_1.728.728
Published: 2017
Journal Articles

Outpatient Administration Of Hyper-CVAD Chemotherapy For Acute Lymphoblastic Leukaemia / Lymphoma Is Safe and Associated With Similar Toxicity Compared To Inpatient Delivery

Emad Uddin Abro, Kirk Morris, Georgina Hodges, Jason P Butler, Cameron Curley, Elango Subramonia Pillai, Glen A Kennedy
Journal: Blood
Blood (2013) 122 (21): 5017.
https://doi.org/10.1182/blood.V122.21.5017.5017
Published: 2013